Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Nexalin Technology Equity Warrants Exp 15th Sept 2025 NXLIW

Healthcare Medical Devices
Nexalin Technology, Inc. is engaged in designing and developing neurostimulation products for the mental health epidemic. The Company has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:NXLIW)

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on May 23

GlobeNewswire 8 days ago

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

GlobeNewswire April 25, 2024

Nexalin Technology CEO Provides Letter to Shareholders

GlobeNewswire April 10, 2024

Nexalin Technology Accelerates Manufacturing of its HALO(TM) Clarity Following Successful Usability, Feasibility, and Electrical Testing

GlobeNewswire April 9, 2024

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity(TM), a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

GlobeNewswire April 4, 2024

Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board

GlobeNewswire April 2, 2024

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego

GlobeNewswire March 28, 2024

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology

GlobeNewswire March 14, 2024

Nexalin Technology Announces Poster Presentation at "State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment"

GlobeNewswire March 13, 2024
View More News ››

Opinion & Analysis (NDAQ:NXLIW)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:NXLIW)

Be the first to post on this bullboard.

E-Power Resources Inc

E-Power Resources Inc

E-Power Resources Inc. is a Canada-based exploration stage company. The Company is engaged principally in the acquisition ...
View More »